These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
    Author: Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F.
    Journal: Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290.
    Abstract:
    The twin aims of this study were to investigate the changes in anti-HBs IgG levels after booster vaccinations and to compare the effects of different vaccine doses in children aged 11-15 years who were both negative for HBsAg and had an Anti-HBs < 10.0 mIU/mL after primary vaccination. Children who were born between 1993 and 1998 and who had completed their Hepatitis B vaccination program in infancy were randomly recruited to the study. The participants were divided into three groups according to their anti-HBs IgG levels: group I had a level < 0.1 mIU/mL; group II 0.1 - < 1.0 mIU/mL, and group III 1.0 - < 10.0 mIU/mL. The booster vaccination program comprised three (20μg) doses of HepB (CHO) vaccine administered at zero, one and six months after they are join this program: anti-HBs levels were measured one month after the first and third vaccinations. Among 448 HBsAg-negative infants, anti-HBs seroconversion rates (defined as an anti-HBs >= 10 mIU/mL) after the first and third vaccinations were 85.5% and 98.6% respectively - these observed differences were statistically significant (χ2 [1dof] = 50.11, p< 0.05). Seroconversion rates and GMTs after the first and third doses were significantly lower for group I children than the other two groups (p< 0.05). Compared, the OR of being negative (anti-HBs< 10mIU/ml) in group I after the first and the third dose were 7.66 (95%CI: 4.35-13.47, P< 0.05) and 20.48 (95% CI: 2.36-177.67, P< 0.05). So the anti-HBs titer levels decay to 10mIU/ml in 11-15 years of age children completed HepB Basic immunization, which need for booster immunization. The effect is better for those children with a relatively higher antibody titer before booster, and the effect of three doses booster is best.
    [Abstract] [Full Text] [Related] [New Search]